Floatz logo

9 assets in B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like

Therapeutic assets addressing B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical CenterP2B (60)
Cytarabine
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical CenterP2B (60)
Mercaptopurine Anhydrous
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical CenterP2B (60)
Prednisone
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical CenterP2B (60)
Methotrexate
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical CenterP2B (58)
Daunomycin
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical CenterP1CC (43)
Pegaspargase
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical CenterP1CC (43)
Venetoclax
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical CenterP1CC (43)
Vincristine Sulfate
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical CenterP1CC (43)